INTERNATIONAL PATENT: THE JOHNS HOPKINS UNIVERSITY FILES APPLICATION FOR "PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED NF-ΚB P50-DEFICIENT IMMATURE MYELOID CELLS"

GENEVA, May 14 -- THE JOHNS HOPKINS UNIVERSITY (3400 N. Charles StreetBaltimore, MD 21218) filed a patent application (PCT/US2024/053558) for "PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED NF-KappaB P50-DEFICIENT IMMATURE MYELOID CELLS" on Oct 30, 2024. With publication no. WO/2025/096537, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FRIEDMAN, Alan D. (c/o The Johns Hopkins University3400 N. Charles StreetBaltimore, MD 21218)

Abstract: The present disclosure relates to compositions comprising prostate-specific membran...